Re-Routing Infliximab Therapy: Subcutaneous Infliximab Opens a Path Towards Greater Convenience and Clinical Benefit
Rieke Alten, Yoorim An, Dong‐Hyeon Kim, Sang-Wook Yoon, Laurent Peyrin‐Biroulet
Topics & Concepts
InfliximabMedicineSubcutaneous injectionRheumatoid arthritisClinical trialAdverse effectDiseaseInternal medicineIntensive care medicineImmunodeficiency and Autoimmune DisordersAutoimmune and Inflammatory Disorders ResearchChronic Lymphocytic Leukemia Research